The global pharmaceutical industry – in the land of shrinking giants. 1. Introduction The case describes the evolution of the industry and its unusual strategic environment. Attention is drawn to environmental pressures from regulators and payers. Key forces driving the industry are discussed‚ including addressing unmet medical need‚ the importance of innovation and time to market‚ and globalisation. The case illustrates how an increasingly hostile environment‚ combined with a decline in R&D
Premium Strategic management Industry Management
Pharmaceutical Price Controls in OECD Countries Implications for U.S. Consumers‚ Pricing‚ Research and Development‚ and Innovation U.S. Department of Commerce International Trade Administration The International Trade Administration (ITA) has as its mission the creation of economic opportunity for U.S. workers and firms by promoting international trade‚ opening foreign markets‚ ensuring compliance with trade laws and agreements‚ and supporting U.S. commercial interests at home and abroad
Premium Pharmaceutical industry Food and Drug Administration Pharmacology
Amity International Business School Amity University Term Paper Report On Pharmaceutical Industry Submitted By: Akansha Neha Sandhu Rijul
Premium Pharmaceutical industry Pharmacology
org/gsk-pays-3-billion-fine/ http://www.nytimes.com/2012/07/03/business/glaxosmithkline-agrees-to-pay-3-billion-in-fraud-settlement.html?_r=0 The pharmaceutical giant and British drug maker‚ GlaxoSmithKline‚ has agreed to plead guilty and pay the government three billion dollars in a health care fraud settlement bought by the FDA. This is the largest settlement involving a pharmaceutical company in recorded history. GSK have admitted to committing three fraud charges. They promoted the off-label use of two anti-depressant
Premium
Institutional Area‚ Behind the Grand Hotel‚ Vasant Kunj‚ New Delhi – 110070 Tel.: 2612409090 / 91; Fax: 26124092 E-mail: administration@srisim.org; Website: www.srisim.org DEVELOPMENT DAY PROJECT REPORT STRATEGIC ALLIANCE IN INDIAN PHARMACEUTICAL INDUSTRY Submitted by: | Name: Jagriti Singh (20090123) Amardeep Tomar(20090106) Shilpa Jaiswal(20090155) Anil Chauhan(20090108) | Batch: | 2009 – 2011. | MANAGING THROUGH WISDOM INTRODUCTION
Premium Pharmaceutical industry Pharmacology Drug discovery
Historical background of the business Today Merck & Co‚ Inc. is one of the most recognizable companies in the pharmaceutical industry. When asked about Merck‚ most people think that it is and always has been a US company. However‚ the company’s history can be traced all the way back to the 1600’s where it was started in Darmstadt‚ Germany. Friedrich Jacob Merck purchased a local store in 1668 where he prepared and sold medicines. The store was called “At the sign of the Angels” and would remain
Premium
Recruitment and Selection: A Study on BEXIMCO Pharmaceuticals A Research Paper Submitted to: Abdul Kader Nazmul Assistant Professor & Head‚ Dept. of Management‚ As a partial fulfillment of the requirement for the HRM course Prepared by: Nahrin Musharraf Sumayea Mahmuda Rezwana Haque Muhammad Shaikh Shahrukh Fall’2009 Dhaka [pic] AMERICAN INTERNATIONAL UNIVERSITY-BANGLADESH Acknowledgement At the very beginning we would like to express our deepest
Premium Recruitment Employment
Introduction In pharmaceutical sales‚ the traditional approach for increasing market share has been brute force – more reps‚ more calls‚ and more talk time. But now‚ the sheer number of reps has caused physicians to severely limit access. As a result sales strategies must evolve from quantity to quality through targeted messaging. (Hall‚ 2004) In December 2006‚ the marketing VP for Sanofi-Aventis stated: “We are so far behind other industries but the good news is that CRM can change marketing practices
Premium Customer relationship management
of some manager of Square Pharmaceuticals Ltd. 1.4 Methodology • The entire report was dependent solely on secondary data‚ taken from the annual report of Square Pharmaceuticals Ltd. and books. • Some primary data were obtained by interview. 1.5 Limitations The limitations to produce this report are as follows:- • The accuracy of the report depends upon the accuracy of the information furnished by our text book and from annual report of Square Pharmaceuticals Ltd. as well. • Inadequate
Premium Strategic management Corporation Marketing
Adv Prof Dev & Res: Project Proposal and Plan Page 1 Mayur Sojitra 000594653 STUDENT NAME: MAYUR POPATLAL SOJITRA STUDENT ID NUMBER: 000594653 PROPOSED TITLE FOR DISSERTATION: Pharmaceutical Industries and CSR in India: Relationship between CSR Activities and Financial Performance of Pharmaceutical Industries Project Overall Aims and Objectives The modern base of globalisation and ethical behaviour has considerably changed the basic philosophy of Corporate Social Responsibility of
Premium Corporate social responsibility Quantitative research Qualitative research